Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward F Patz

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Plos One|June 16, 2021
Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosisRyan T Bushey, Elizabeth B Gottlin, Michael J Campa, et al.
Cancer Immunology Research|July 29, 2015
Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic StrategyMichael J Campa, Elizabeth B Gottlin, Ryan T Bushey, et al.
Cancer Research|April 3, 2003
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancerMichael J Campa, Michael Z Wang, Brandon Howard, et al.
Proteomics|September 16, 2003
Analysis of human serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometryMichael Z Wang, Brandon Howard, Michael J Campa, et al.
Seminars in Immunology|January 18, 2025
Complement regulators as novel targets for anti-cancer therapy: A comprehensive reviewRuchi Saxena, Elizabeth B Gottlin, Michael J Campa, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2023
Characterizing Lung-RADS category 4 lesions in a university lung cancer screening programMadison Kocher Wulfeck, Samuel Plesner, James E Herndon, et al.
Annals of Internal Medicine|September 10, 2014
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 populationPaul F Pinsky, David S Gierada, William Hocking, et al.
Journal of the American Society for Mass Spectrometry|July 26, 2008
Throughput and efficiency of a mass spectrometry-based screening assay for protein-ligand binding detectionErin D Hopper, Petra L Roulhac, Michael J Campa, et al.
Plos One|November 9, 2018
A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancerJeffrey R Ashton, Elizabeth B Gottlin, Edward F Patz, et al.
Journal of Biomolecular Screening|January 28, 2009
Isolation of novel EGFR-specific VHH domainsElizabeth B Gottlin, Xiangrong Guan, Charles Pegram, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Plos One|June 16, 2021
Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosisRyan T Bushey, Elizabeth B Gottlin, Michael J Campa, et al.
Cancer Immunology Research|July 29, 2015
Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic StrategyMichael J Campa, Elizabeth B Gottlin, Ryan T Bushey, et al.
Cancer Research|April 3, 2003
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancerMichael J Campa, Michael Z Wang, Brandon Howard, et al.
Proteomics|September 16, 2003
Analysis of human serum proteins by liquid phase isoelectric focusing and matrix-assisted laser desorption/ionization-mass spectrometryMichael Z Wang, Brandon Howard, Michael J Campa, et al.
Seminars in Immunology|January 18, 2025
Complement regulators as novel targets for anti-cancer therapy: A comprehensive reviewRuchi Saxena, Elizabeth B Gottlin, Michael J Campa, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2023
Characterizing Lung-RADS category 4 lesions in a university lung cancer screening programMadison Kocher Wulfeck, Samuel Plesner, James E Herndon, et al.
Annals of Internal Medicine|September 10, 2014
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 populationPaul F Pinsky, David S Gierada, William Hocking, et al.
Journal of the American Society for Mass Spectrometry|July 26, 2008
Throughput and efficiency of a mass spectrometry-based screening assay for protein-ligand binding detectionErin D Hopper, Petra L Roulhac, Michael J Campa, et al.
Plos One|November 9, 2018
A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancerJeffrey R Ashton, Elizabeth B Gottlin, Edward F Patz, et al.
Journal of Biomolecular Screening|January 28, 2009
Isolation of novel EGFR-specific VHH domainsElizabeth B Gottlin, Xiangrong Guan, Charles Pegram, et al.
Pageof 11